CLINICAL_TRIALS
trial_result
· 2018-06-29
Clinical Trial Update: Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy [Phase 2]
Summary
The Phase 2 study of ARB-001467 in chronic hepatitis B patients receiving nucleos(t)ide therapy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arbutus Biopharma Corporation | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED